Filed: 5/15/2025ACC: 0001636587-25-000017
📋 What this filing means
ACORN CAPITAL ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 22 equity positions with a total reported market value of $143.70M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
22
Positions
$143.70M
Total AUM (reported)
37.60M
Total Shares
Allocation by class
COM$128.03M89.1%
COM NEW$8.54M5.9%
COM STK$5.45M3.8%
CLASS A COM$856.5K0.6%
COMMON STOCK$822.6K0.6%
Portfolio Concentration
Top 3$58.82M40.9%
4–10$61.25M42.6%
11–25$23.63M16.4%
Top 3 weight
40.9%
Top 10 weight
83.6%
Voting Authority Distribution
Total shares with voting rights: 37.60M
Sole
Full voting authority
37.60M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole22
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings22
Rows:
CG ONCOLOGY INC
SOLEShares1.13M
TypeSH
Market value$27.72M
19.29%
Sole
1.13M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.52M
TypeSH
Market value$16.77M
11.67%
Sole
1.52M
Shared
0.00
None
0.00
Y-MABS THERAPEUTICS INC
SOLEShares3.24M
TypeSH
Market value$14.33M
9.97%
Sole
3.24M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares2.14M
TypeSH
Market value$13.49M
9.39%
Sole
2.14M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares2.15M
TypeSH
Market value$12.16M
8.46%
Sole
2.15M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares3.94M
TypeSH
Market value$11.66M
8.12%
Sole
3.94M
Shared
0.00
None
0.00
BICARA THERAPEUTICS
SOLEShares643.38K
TypeSH
Market value$8.38M
5.83%
Sole
643.38K
Shared
0.00
None
0.00
PROTARA THERAPEUTICS INC
SOLEShares1.28M
TypeSH
Market value$5.45M
3.79%
Sole
1.28M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares1.97M
TypeSH
Market value$5.44M
3.79%
Sole
1.97M
Shared
0.00
None
0.00
CYBIN INC
SOLEShares734.39K
TypeSH
Market value$4.66M
3.25%
Sole
734.39K
Shared
0.00
None
0.00
CARDIF ONCOLOGY INC
SOLEShares1.44M
TypeSH
Market value$4.53M
3.15%
Sole
1.44M
Shared
0.00
None
0.00
OPTINOSE INC
SOLEShares422.81K
TypeSH
Market value$3.88M
2.70%
Sole
422.81K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares452.11K
TypeSH
Market value$2.73M
1.90%
Sole
452.11K
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares1.14M
TypeSH
Market value$2.03M
1.41%
Sole
1.14M
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares7.31M
TypeSH
Market value$1.75M
1.22%
Sole
7.31M
Shared
0.00
None
0.00
MURAL ONCOLOGY PLC
SOLEShares1.27M
TypeSH
Market value$1.60M
1.11%
Sole
1.27M
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares590.51K
TypeSH
Market value$1.45M
1.01%
Sole
590.51K
Shared
0.00
None
0.00
BIOATLA INC
SOLEShares4.03M
TypeSH
Market value$1.41M
0.98%
Sole
4.03M
Shared
0.00
None
0.00
Q32 BIO INC.
SOLEShares803.42K
TypeSH
Market value$1.33M
0.92%
Sole
803.42K
Shared
0.00
None
0.00
VYNE THERAPEUTICS INC
SOLEShares785.94K
TypeSH
Market value$1.24M
0.86%
Sole
785.94K
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares199.19K
TypeSH
Market value$856.5K
0.60%
Sole
199.19K
Shared
0.00
None
0.00
ACRIVON THERAPEUTICS INC
SOLEShares405.24K
TypeSH
Market value$822.6K
0.57%
Sole
405.24K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 1.13M | SH | $27.72M 19.29% | 1.13M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.52M | SH | $16.77M 11.67% | 1.52M | 0.00 | 0.00 |
Y-MABS THERAPEUTICS INCSOLE | COM | 3.24M | SH | $14.33M 9.97% | 3.24M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 2.14M | SH | $13.49M 9.39% | 2.14M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 2.15M | SH | $12.16M 8.46% | 2.15M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 3.94M | SH | $11.66M 8.12% | 3.94M | 0.00 | 0.00 |
BICARA THERAPEUTICSSOLE | COM | 643.38K | SH | $8.38M 5.83% | 643.38K | 0.00 | 0.00 |
PROTARA THERAPEUTICS INCSOLE | COM STK | 1.28M | SH | $5.45M 3.79% | 1.28M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 1.97M | SH | $5.44M 3.79% | 1.97M | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 734.39K | SH | $4.66M 3.25% | 734.39K | 0.00 | 0.00 |
CARDIF ONCOLOGY INCSOLE | COM | 1.44M | SH | $4.53M 3.15% | 1.44M | 0.00 | 0.00 |
OPTINOSE INCSOLE | COM NEW | 422.81K | SH | $3.88M 2.70% | 422.81K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM | 452.11K | SH | $2.73M 1.90% | 452.11K | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 1.14M | SH | $2.03M 1.41% | 1.14M | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM | 7.31M | SH | $1.75M 1.22% | 7.31M | 0.00 | 0.00 |
MURAL ONCOLOGY PLCSOLE | COM | 1.27M | SH | $1.60M 1.11% | 1.27M | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 590.51K | SH | $1.45M 1.01% | 590.51K | 0.00 | 0.00 |
BIOATLA INCSOLE | COM | 4.03M | SH | $1.41M 0.98% | 4.03M | 0.00 | 0.00 |
Q32 BIO INC.SOLE | COM | 803.42K | SH | $1.33M 0.92% | 803.42K | 0.00 | 0.00 |
VYNE THERAPEUTICS INCSOLE | COM | 785.94K | SH | $1.24M 0.86% | 785.94K | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | CLASS A COM | 199.19K | SH | $856.5K 0.60% | 199.19K | 0.00 | 0.00 |
ACRIVON THERAPEUTICS INCSOLE | COMMON STOCK | 405.24K | SH | $822.6K 0.57% | 405.24K | 0.00 | 0.00 |